The C677T polymorphism of the methylenetetrahydrofolate reductase gene and susceptibility to late-onset Alzheimer's disease

被引:5
|
作者
Yi, Jian [1 ]
Xiao, Lan [3 ]
Zhou, Sheng-Qiang [3 ]
Zhang, Wen-Jiang [2 ]
Liu, Bai-Yan [1 ,2 ]
机构
[1] Hunan Univ Tradit Chinese Med, Key Lab Internal Med, Hosp 1, Changsha 410007, Hunan, Peoples R China
[2] Yiyang Med Coll, Yiyang 413000, Hunan, Peoples R China
[3] Hunan Univ Tradit Chinese Med, Changsha 410208, Hunan, Peoples R China
来源
OPEN MEDICINE | 2019年 / 14卷 / 01期
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; MTHFR; C677T; Polymorphism; Meta-analysis; MTHFR GENE; COMMON POLYMORPHISMS; PLASMA HOMOCYSTEINE; FOLIC-ACID; ASSOCIATION; VARIANTS; RISK; METAANALYSIS; CD2AP; EPHA1;
D O I
10.1515/med-2019-0006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Folate metabolism makes a crucial contribution towards late-onset Alzheimer's disease (LOAD). Moreover, methylenetetrahydrofolate reductase (MTHFR) constitutes the primary enzyme of the folate pathway. We hypothesize that there is an association of C677T polymorphism in the MTHFR gene with the susceptibility to LOAD. Previous published research has investigated the link between the MTHFR C677T polymorphisms and LOAD susceptibility; nevertheless, the findings have continued to be not only controversial, but also indecisive. Accordingly, we carried out the present meta-analysis for the assessment of the potential link that exists between the MTHFR C677T polymorphism and the susceptibility to LOAD. Furthermore, we carried out a literature search of the PubMed, EMBASE, Cochrane Library, and WanFang database up to August 10, 2018. The odds ratios (ORs) with the respective 95% confidence interval (95%CI) were put to use for the evaluation of the robustness of the link of the MTHFR C677T polymorphism with the vulnerability to LOAD. All statistical analyses were carried out using STATA 15.0. An aggregate of 14 case-control research works was retrieved, involving 2,467 LOAD patients as well as 2,877 controls. We found that a substantial link exists between C677T polymorphism and LOAD risk in a codominant framework (TC vs. CC: OR=1.22, 95%CI=1.00-1.49, P=0.049). In addition to the stratified analysis based on ethnicity, which suggested that C677T polymorphism was likely linked only to an augmented threat of LOAD in Asians, it did not exist among Caucasians. Furthermore, in the subgroup analysis carried out using APOE epsilon 4 status, a substantial increase in the susceptibility to LOAD was detected in APOE epsilon 4 carriers as well as non-APOE epsilon 4 carriers. In sum, the current meta-analysis revealed that MTHFR C677T polymorphism was associated with susceptibility to LOAD. Further extensive case-control studies are required.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 50 条
  • [21] The C677T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in patients with dementia
    Bednarska-Makaruk, M.
    Graban, A.
    Lojkowska, W.
    Bochynska, A.
    Wehr, H.
    Ryglewicz, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 60 - 60
  • [22] Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis
    Rai, Vandana
    MOLECULAR NEUROBIOLOGY, 2017, 54 (02) : 1173 - 1186
  • [23] No association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer
    Srivastava, Anvesha
    Pandey, Sachchida N.
    Pandey, P.
    Choudhuri, Gourdas
    Mittal, Balraj
    DNA AND CELL BIOLOGY, 2008, 27 (03) : 127 - 132
  • [25] Methylenetetrahydrofolate reductase C677T polymorphism and pregnancy complications
    Stonek, Felix
    Hafner, Erich
    Philipp, Karl
    Hefler, Lukas A.
    Bentz, Eva-Katrin
    Tempfer, Clemens B.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (02): : 363 - 368
  • [26] Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia
    Golbahair, Jamal
    Aminzadeh, Mohammad A.
    Al-Shboul, Qasim M.
    Kassab, Salah
    Rezaian, Golam R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2007, 17 (06) : 462 - 467
  • [27] MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis
    Vasku, Vladimir
    Bienertova-Vasku, Julie
    Necas, Miroslav
    Vasku, Anna
    CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 9 (04) : 327 - 331
  • [28] Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis
    Vandana Rai
    Molecular Neurobiology, 2017, 54 : 1173 - 1186
  • [29] Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in ischemic vascular disease
    Sanchez-Marin, B.
    Grasa, J. M.
    REVISTA DE NEUROLOGIA, 2006, 43 (10) : 630 - 636
  • [30] Is methylenetetrahydrofolate reductase C677T polymorphism associated with hyperuricemia?
    Fan, Shujun
    Yang, Boyi
    Zhi, Xueyuan
    Wang, Yanxun
    Wei, Jian
    Sun, Guifan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7518 - +